Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Ting

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Nature Communications|January 2, 2025
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis productAvanish Mishra, Shih-Bo Huang, Taronish Dubash, et al.
Nature Cancer|February 5, 2022
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialAparna R Parikh, Annamaria Szabolcs, Jill N Allen, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
The Pdgfd-Pdgfrb axis orchestrates tumor-nerve crosstalk in pancreatic cancerPeter Wang, Nicole Lester, Ella Perrault, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis productAvanish Mishra, Shih-Bo Huang, Taronish Dubash, et al.
Cancer Research|April 8, 2024
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal AdenocarcinomaSamantha Guinn, Benedict Kinny-Köster, Joseph A Tandurella, et al.
JAMA Oncology|May 31, 2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical TrialJanet E Murphy, Jennifer Y Wo, David P Ryan, et al.
Nature Cancer|March 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancersLei Shi, William Shen, Mindy I Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its StromaMarc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Cancer Discovery|May 22, 2019
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic CholangiocarcinomaLipika Goyal, Lei Shi, Leah Y Liu, et al.
Nature Medicine|November 21, 2019
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancersAparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Nature Communications|January 2, 2025
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis productAvanish Mishra, Shih-Bo Huang, Taronish Dubash, et al.
Nature Cancer|February 5, 2022
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialAparna R Parikh, Annamaria Szabolcs, Jill N Allen, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
The Pdgfd-Pdgfrb axis orchestrates tumor-nerve crosstalk in pancreatic cancerPeter Wang, Nicole Lester, Ella Perrault, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis productAvanish Mishra, Shih-Bo Huang, Taronish Dubash, et al.
Cancer Research|April 8, 2024
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal AdenocarcinomaSamantha Guinn, Benedict Kinny-Köster, Joseph A Tandurella, et al.
JAMA Oncology|May 31, 2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical TrialJanet E Murphy, Jennifer Y Wo, David P Ryan, et al.
Nature Cancer|March 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancersLei Shi, William Shen, Mindy I Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its StromaMarc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Cancer Discovery|May 22, 2019
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic CholangiocarcinomaLipika Goyal, Lei Shi, Leah Y Liu, et al.
Nature Medicine|November 21, 2019
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancersAparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.
Pageof 16